Bristol-Myers Squibb donates $6.9 million to benefit cancer patients

PRINCETON, N.J. — Drug maker Bristol-Myers Squibb has donated $6.9 million to a nonprofit group that helps people pay for medical treatments, the company said.



Bristol made the donation to the HealthWell Foundation, which provides financial assistance to eligible people for covering co-insurance, co-payments, healthcare premiums and deductibles for certain treatments. The drug maker's donation is targeted toward underinsured cancer patients.



"Bristol-Myers Squibb had robust patient assistance programs for cancer patients, and this contribution reinforces our commitment to helping patients gain access to the medicines they need," Bristol VP U.S. medical John Tsai said. "We are proud to support the HealthWell Foundation in its mission to reduce barriers to care for underinsured patients."

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.